title: Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.
authors: Kottil W
authors: KW
authors: Rammohan
authors: Milissa R
authors: MR
authors: Ortega
authors: Silvia R
authors: SR
authors: Delgado
authors: Leticia
authors: L
authors: Tornes
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal